Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Corlett

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular Endocrinology (Baltimore, Md.)|January 31, 2009
DISP3, a sterol-sensing domain-containing protein that links thyroid hormone action and cholesterol metabolismMartina Zikova, Alicia Corlett, Zdenka Bendova, et al.
Journal of Nuclear Medicine Technology|December 28, 2020
<sup>90</sup>Y PET for Qualitative and Quantitative Assessment of Residual Activity in Delivery Apparatus After RadioembolizationYung Hsiang Kao, Alicia Corlett, Katrina Jorna, et al.
FEBS Letters|October 5, 2014
DISP3 promotes proliferation and delays differentiation of neural progenitor cellsMartina Zíková, Jana Konířová, Karolína Ditrychová, et al.
Journal of Nuclear Medicine Technology|April 20, 2022
Indirect Lung Absorbed Dose Verification by <sup>90</sup>Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of ConceptYung Hsiang Kao, Calvin Gan, Alicia Corlett, et al.
Scientific Reports|January 31, 2017
Modulated DISP3/PTCHD2 expression influences neural stem cell fate decisionsJana Konířová, Jana Oltová, Alicia Corlett, et al.
Science (New York, N.Y.)|June 27, 2009
Mitochondrial STAT3 supports Ras-dependent oncogenic transformationDaniel J Gough, Alicia Corlett, Karni Schlessinger, et al.
Theranostics|March 20, 2024
Precision peptide theranostics: developing <i>N</i>- to <i>C</i>-terminus optimized theranostics targeting cholecystokinin-2 receptorMarwa N Rahimi, Alicia Corlett, Jessica Van Zuylekom, et al.
Journal of Medical Genetics|May 7, 2013
Upregulation of RCAN1 causes Down syndrome-like immune dysfunctionKatherine R Martin, Daniel Layton, Natalie Seach, et al.
Journal of Medicinal Chemistry|July 26, 2023
Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive CancersAlicia Corlett, Jo-Anne Pinson, Marwa N Rahimi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
First Images on a Next-Generation Extended-Field-of-View Digital Bismuth Germanium Oxide Total-Body PET/CTMichael S Hofman, Alicia Corlett, Cameron Pain, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Endocrinology (Baltimore, Md.)|January 31, 2009
DISP3, a sterol-sensing domain-containing protein that links thyroid hormone action and cholesterol metabolismMartina Zikova, Alicia Corlett, Zdenka Bendova, et al.
Journal of Nuclear Medicine Technology|December 28, 2020
<sup>90</sup>Y PET for Qualitative and Quantitative Assessment of Residual Activity in Delivery Apparatus After RadioembolizationYung Hsiang Kao, Alicia Corlett, Katrina Jorna, et al.
FEBS Letters|October 5, 2014
DISP3 promotes proliferation and delays differentiation of neural progenitor cellsMartina Zíková, Jana Konířová, Karolína Ditrychová, et al.
Journal of Nuclear Medicine Technology|April 20, 2022
Indirect Lung Absorbed Dose Verification by <sup>90</sup>Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of ConceptYung Hsiang Kao, Calvin Gan, Alicia Corlett, et al.
Scientific Reports|January 31, 2017
Modulated DISP3/PTCHD2 expression influences neural stem cell fate decisionsJana Konířová, Jana Oltová, Alicia Corlett, et al.
Science (New York, N.Y.)|June 27, 2009
Mitochondrial STAT3 supports Ras-dependent oncogenic transformationDaniel J Gough, Alicia Corlett, Karni Schlessinger, et al.
Theranostics|March 20, 2024
Precision peptide theranostics: developing <i>N</i>- to <i>C</i>-terminus optimized theranostics targeting cholecystokinin-2 receptorMarwa N Rahimi, Alicia Corlett, Jessica Van Zuylekom, et al.
Journal of Medical Genetics|May 7, 2013
Upregulation of RCAN1 causes Down syndrome-like immune dysfunctionKatherine R Martin, Daniel Layton, Natalie Seach, et al.
Journal of Medicinal Chemistry|July 26, 2023
Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive CancersAlicia Corlett, Jo-Anne Pinson, Marwa N Rahimi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
First Images on a Next-Generation Extended-Field-of-View Digital Bismuth Germanium Oxide Total-Body PET/CTMichael S Hofman, Alicia Corlett, Cameron Pain, et al.
Pageof 2